Loading clinical trials...
Loading clinical trials...
MaxiMoM: Individualized Fortification of Human Milk for Infants Born ≤ 1250 g; a Three Arm Randomized Clinical Trial
Very low birth weight infants have increased nutritional needs. Extra nutrients are added to their human milk feeds to help improve their nutritional status, growth and neurodevelopment. Standard fortification of human milk is routine in most neonatal units in North America, but despite the added nutrients, infants are often discharged from hospitals with poor growth, and their neurodevelopment remains suboptimal. Two individualized fortification methods, target and BUN adjustable, have been proposed to improve the nutrient supply to infants. However, there is currently insufficient evidence to support the implementation of individualized fortification or one method over the other. Therefore, this study will randomly assign very low birth weight infants to receive feeds fortified according to standard, target or BUN adjustable fortification methods until the end of the feeding intervention. Feedings will be prepared in milk preparation rooms to ensure caregivers and outcomes assessor remain blinded to feeding allocation. Growth, morbidities, and nutrient intakes will be determined throughout hospitalization and skinfolds assessed at 36 weeks. At 4 months CA, growth and body composition will be determined by air displacement plethysmography on a subset of infants. Neurodevelopment will be assessed using the Bayley Scales of Infant and Toddler Development, at 18-24 months CA.
The end of the feeding intervention is defined as: the infant is 36+0 weeks CA, is discharged home, or receives two oral feeds daily for three consecutive days without top-up. The exception to the 36+0 weeks intervention end-date is in the situation where an infant remains hospitalized but has not completed at least four weeks of the feeding intervention (i.e. 4 weeks following Study Day 1).
Age
0 - 0 years
Sex
ALL
Healthy Volunteers
No
University of Alberta
Edmonton, Alberta, Canada
William Osler Health System-Brampton Civic Hospital
Brampton, Ontario, Canada
William Osler Health System-Etobicoke General Hospital
Etobicoke, Ontario, Canada
Markham Stouffville Hospital
Markham, Ontario, Canada
Trillium Health Partners-Missisauga Hospital
Mississauga, Ontario, Canada
Trillium Health Partners-Credit Valley Hospital
Mississauga, Ontario, Canada
Southlake Regional Health Centre
Newmarket, Ontario, Canada
North York General Hospital
North York, Ontario, Canada
Humber River Hospital
North York, Ontario, Canada
Lakeridge Health
Oshawa, Ontario, Canada
Start Date
November 11, 2021
Primary Completion Date
July 1, 2026
Completion Date
July 1, 2026
Last Updated
July 31, 2025
615
ESTIMATED participants
Standard fortification
OTHER
Target fortification
OTHER
BUN adjustable fortification
OTHER
Lead Sponsor
The Hospital for Sick Children
NCT06965842
NCT05399667
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions